CRM Reimagined: Present Day Realities

About the Episode

Welcome to The Improzone! In this three-part mini-series, we continue the journey through the evolving world of CRM in Life Sciences, moving from foundational history into the complex realities shaping decisions today.

In Part 2, CRM Reimagined: Present Day Realities, Improzo’s Chief Data & Analytics Officer Jane Urban is joined by Jason Harlander, Executive Director, Technology Management at Improzo, to unpack what CRM transformation really looks like in the current landscape. The conversation explores how pharma organizations are navigating the increasingly complex choice between Veeva Vault CRM and Salesforce Life Sciences Cloud, and why this decision is far more than a technology upgrade.

This episode goes deeper into the real-world pressures behind CRM modernization, from fragmented enterprise ecosystems and integration complexity to change management challenges and shifting expectations driven by AI-led narratives. It’s a grounded discussion on what’s actually influencing decisions inside boardrooms and operating teams today.

This episode is about understanding the messiness of the present and why clarity in decision-making matters more than ever.

Highlights from the Episode

• Why CRM decisions today are driven more by enterprise architecture than by product features alone
• How Veeva and Salesforce are reshaping pharma CRM with competing platform ecosystems
• The hidden complexity of switching costs across clinical, regulatory, and commercial systems
• Why integration ecosystems and upstream/downstream dependencies significantly impact migration efforts
• How change management becomes a defining factor, especially for field and commercial teams
• Why “waiting it out” is becoming a risky strategy as timelines tighten and transitions grow longer
• How AI positioning from both platforms is influencing decisions, even as real-world outcomes are still emerging
• Why early-stage biotech companies risk defaulting into ecosystems through tools like Veeva Basics
• What truly separates successful CRM decisions from costly, delayed transformations

Tune In for the Next Episode

In Part 3 of this mini-series, we’ll explore where CRM is heading next, from emerging AI-native capabilities to the future of unified life sciences ecosystems, and what organizations should prepare for today to stay ahead tomorrow.